Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-IT

BACKGROUND: An increased risk of malignancy was reported with simvastatin/ezetimibe in 1,873 patients in the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) trial. OBJECTIVES: The purpose of this study was to clarify this unexpected finding in a larger sample size of patients stabilized after ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Giugliano, Robert P., Gencer, Baris, Wiviott, Stephen D., Park, Jeong-Gun, Fuchs, Charles S., Goessling, Wolfram, Musliner, Thomas A., Tershakovec, Andrew M., Blazing, Michael A., Califf, Robert, Cannon, Christopher P., Braunwald, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352126/
https://www.ncbi.nlm.nih.gov/pubmed/34396246
http://dx.doi.org/10.1016/j.jaccao.2020.07.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352126/
https://www.ncbi.nlm.nih.gov/pubmed/34396246
http://dx.doi.org/10.1016/j.jaccao.2020.07.008

Ejemplares similares